Grover Bagby, M.D., director of the OHSU Cancer Institute, has been appointed by the American Society of Hematology and  the American Association for Cancer Research as one of the 17 members of the national Think Tank on Hematologic Malignancies.

The Think Tank was formed to assess the state of cancer biology research and to recommend to the societies a research agenda that would accelerate research progress in blood cancers.

Bagby is also a professor of medicine (hematology and medical oncology), and molecular and medical genetics, OHSU School of Medicine; and a member of the Association of American Physicians.  He is the founding director of the OHSU Cancer Institute, the only cancer center designated by the National Cancer Institute between Sacramento and Seattle. It comprises some 120 clinical researchers, basic scientists and population scientists who work together to translate scientific discoveries into longer and better lives for Oregon's cancer patients. In the lab, basic scientists examine cancer cells and normal cells to uncover molecular abnormalities that cause the disease. This basic science informs more than 200 clinical trials conducted at the OHSU Cancer Institute.